Search Results - FA Castro
- Showing 1 - 6 results of 6
-
1
-
2
-
3
IMMUNOPHENOTYPIC PROFILING REVEALS ALTERED EXPRESSION OF PLATELET ACTIVATION MARKERS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS by VL Bassan, PC Paolini, LMG Ramos, FR Morais, PVB Palma, LC Palma, PMM Garibaldi, LL Figueired-Pontes, FA Castro
Published in Hematology, Transfusion and Cell Therapy (2023-10-01)Get full text
Article -
4
GENE AND METABOLITE SIGNATURES IN CHRONIC MYELOID LEUKEMIA PROGRESSION: IMPLICATIONS FOR THERAPEUTIC RESISTANCE AND BIOMARKER DISCOVERY by FC Almeida, RL Simões, MG Berzoti-Coelho, L Ambrosio, LFP Chaim, LL Figueiredo-Pontes, CA Sorgi, LH Faccioli, TM Malta, FA Castro
Published in Hematology, Transfusion and Cell Therapy (2024-10-01)Get full text
Article -
5
IMMUNOLOGICAL PROFILES OF CYTOTOXIC CELLS IS ASSOCIATED WITH TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA by LS Binelli, LC Palma, CAB Garcia, LO Marani, M Medeiros, AG Carvalho, PS Scheucher, JLS Schiavinato, PMM Garibaldi, RS Welner, FA Castro, KBB Pagnano, LL Figueiredo-Pontes
Published in Hematology, Transfusion and Cell Therapy (2024-10-01)Get full text
Article -
6
FREQUÊNCIA E ATIVAÇÃO DE CÉLULAS CITOTÓXICAS ANTITUMORAIS SÃO BIOMARCADORES DE RESPOSTA E REMISSÃO LIVRE DE TRATAMENTO NA LEUCEMIA MIELOIDE CRÔNICA by LS Binelli, LC Palma, CAB Garcia, LO Marani, M Medeiros, IA Lopes, PS Scheucher, JL Schiavinato, F Traina, PMM Garibaldi, FA Castro, VL Bassan, GO Duarte, KBB Pagnano, LL Figueired-Pontes
Published in Hematology, Transfusion and Cell Therapy (2023-10-01)Get full text
Article
